Akebia Therapeutics Inc is a fully integrated biopharmaceutical company, primarily focusing on developing and commercializing novel therapeutics for people with kidney disease. The company's portfolio ...
Arlington, VA, May 17, 2022 (GLOBE NEWSWIRE) -- The Digital Therapeutics Alliance (DTA), a global non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven ...
The Medicaid and CHIP Access to Prescription Digital Therapeutics Act seeks to expand care options that can help improve health outcomes and quality of life for those facing barriers to healthcare.
Beam Therapeutics (BEAM) announced it had acquired Guide Therapeutics, a maker of components for genetic medicines — and Beam stock tumbled. Guide makes molecular "vehicles" to deliver genetic ...
Gene therapy developer Beam Therapeutics Inc. has acquired drug delivery specialist Guide Therapeutics Inc. in a deal valued at up to $440 million, adding yet another piece of the integrated platform ...
CAMBRIDGE, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new ...
DUBLIN, April 22, 2020 /PRNewswire/ -- The "Drug Overdose - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This Pharmaceutical and Healthcare pipeline ...
Gene therapy developer Beam Therapeutics Inc. has acquired drug delivery specialist Guide Therapeutics Inc. in a deal valued at up to $440 million, adding yet another piece of the integrated platform ...
CAMBRIDGE, Mass., Dec. 12, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today shared a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results